pharma
Amersham Sorin.S.r.l
Amersham Sorin.S.r.l.
Amersham Sorin.S.r.l drug portfolio β 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
EU HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Programs
- 0
- Drugs
- 0
- Patents
- 2
Amersham Sorin.S.r.l pipeline
Portfolio lens on 0 drugs and development assets β regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Amersham Sorin.S.r.l drug portfolio β 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.